and its potential application to neonates and advances in the treatment of persistent pulmonary hypertension (PPHN) of the newborn. Conclusions: Despite being over 30 years old, the practice of ...

Neonatal hypertension, while uncommon, is increasingly recognized in the context of neonatal care, particularly in premature infants. As survival rates for these infants improve due to ...

Results from 40 infants with persistent pulmonary hypertension of the newborn (PPHN), an often fatal complication, were compared with those of 61 randomly selected, healthy, full-term infants.

Doctors at the Institute of Medical Sciences and SUM Hospital here have successfully treated a newborn weighing 2 kilogram ...

The division currently has 26 faculty members. Clinical research interests of our faculty include: respiratory distress syndrome, neonatal infections and immunology, persistent pulmonary hypertension, ...

Severe cases of pulmonary hypertension need to be detected and treated as rapidly as possible. The sooner treatment begins, the better the prognosis for the newborn infant. Yet making the correct ...

The LungFit PH device was approved ini 2022 by the U.S. Food and Drug Administration and the European Union to treat PPHN.